Saraceni, Francesco; Agostini, Vanessa; Vincenzi, Daniele; Lanza, Francesco, Post-thaw viability of cryopreserved peripheral blood stem cells: what are we actually looking at?, «DRUGS AND CELL THERAPIES IN HEMATOLOGY», 2016, 2016, pp. 85 - 94 [Scientific article]
Necchi A.; Miceli R.; Bregni M.; Bokemeyer C.; Berger L. A.; Oechsle K.; Schumacher K.; Kanfer E.; Bourhis J. H.; Massard C.; Laszlo D.; Montoro J.; Flechon A.; Arpaci F.; Secondino S.; Wuchter P.; Dreger P.; Crysandt M.; Worel N.; Kruger W.; Ringhoffer M.; Unal A.; Nagler A.; Campos A.; Wahlin A.; Michieli M.; Sucak G.; Donnini I.; Schots R.; Ifrah N.; Badoglio M.; Martino M.; Raggi D.; Giannatempo P.; Rosti G.; Pedrazzoli P.; Lanza F., Prognostic impact of progression to induction chemotherapy and prior paclitaxel therapy in patients with germ cell tumors receiving salvage high-dose chemotherapy in the last 10 years: A study of the European Society for Blood and Marrow Transplantation Solid Tumors Working Party, «BONE MARROW TRANSPLANTATION», 2016, 51, pp. 384 - 390 [Scientific article]
Ravelli A.; Reuben J. M.; Lanza F.; Anfossi S.; Cappelletti M. R.; Zanotti L.; Gobbi A.; Senti C.; Brambilla P.; Milani M.; Spada D.; Pedrazzoli P.; Martino M.; Bottini A.; Generali D., Breast cancer circulating biomarkers: advantages, drawbacks, and new insights, «TUMOR BIOLOGY», 2015, 36, pp. 6653 - 6665 [Scientific article]
Castagnetti, F.; Gugliotta, G.; Baccarani, M.; Breccia, M.; Specchia, G.; Levato, L.; Abruzzese, E.; Rossi, G.; Iurlo, A.; Martino, B.; Pregno, P.; Stagno, F.; Cuneo, A.; Bonifacio, M.; Gobbi, M.; Russo, D.; Gozzini, A.; Tiribelli, M.; de Vivo, A.; Alimena, G.; Cavo, M.; Martinelli, G.; Pane, F.; Saglio, G.; Rosti, G.; GIMEMA CML Working Party; Palandri, F.; Testoni, N.; Luatti, S.; Soverini, S.; Iacobucci, I.; Bochicchio, M.T.; Apolinari, M.; Fogli, M.; Cervello, I.; Lanza, F.;, Differences among young adults, adults and elderly chronic myeloid leukemia patients, «ANNALS OF ONCOLOGY», 2015, 26, pp. 185 - 192 [Scientific article]
Martino M.; Lanza F.; Demirer T.; Moscato T.; Secondino S.; Pedrazzoli P., Erythropoiesis-stimulating agents in allogeneic and autologous hematopoietic stem cell transplantation, «EXPERT OPINION ON BIOLOGICAL THERAPY», 2015, 15, pp. 195 - 211 [Scientific article]
Passweg J. R.; Baldomero H.; Bader P.; Bonini C.; Cesaro S.; Dreger P.; Duarte R. F.; Dufour C.; Falkenburg J. H. F.; Farge-Bancel D.; Gennery A.; Kroger N.; Lanza F.; Nagler A.; Sureda A.; Mohty M., Hematopoietic SCT in Europe 2013: Recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants, «BONE MARROW TRANSPLANTATION», 2015, 50, pp. 476 - 482 [Scientific article]
Necchi A.; Lanza F.; Rosti G.; Martino M.; Fare E.; Pedrazzoli P., High-dose chemotherapy for germ cell tumors: Do we have a model?, «EXPERT OPINION ON BIOLOGICAL THERAPY», 2015, 15, pp. 33 - 44 [Scientific article]
Pedrazzoli P; Martino M; Delfanti S; Generali D; Bregni M; Lanza F, High-dose chemotherapy with autologous hematopoietic stem cell transplantation in high-risk breast cancer patients. on behalf of the EBMT STWP, «JOURNAL OF THE NATIONAL CANCER INSTITUTE. MONOGRAPHS», 2015, 2015, pp. 70 - 75 [Scientific article]
Grisafi D.; Maestro A.; Grumi C.; Piazzoni L.; Tirone G.; Fiore W.; Tessari R.; Gianardi V.; Gatti M.; Tasca F.; Generali D.; Ravelli A.; Lanza F.; Scaglione F., Ibrutinib: from bench side to clinical implications, «MEDICAL ONCOLOGY», 2015, 32, Article number: 225 , pp. 1 - 10 [Scientific article]
Ravelli A.; Reuben J. M.; Lanza F.; Anfossi S.; Cappelletti M. R.; Zanotti L.; Gobbi A.; Milani M.; Spada D.; Pedrazzoli P.; Martino M.; Bottini A.; Generali D., Immune-related strategies driving immunotherapy in breast cancer treatment: A real clinical opportunity, «EXPERT REVIEW OF ANTICANCER THERAPY», 2015, 15, pp. 689 - 702 [Scientific article]
Sureda A.; Bader P.; Cesaro S.; Dreger P.; Duarte R. F.; Dufour C.; Falkenburg J. H. F.; Farge-Bancel D.; Gennery A.; Kroger N.; Lanza F.; Marsh J. C.; Nagler A.; Peters C.; Velardi A.; Mohty M.; Madrigal A., Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: Current practice in Europe, 2015, «BONE MARROW TRANSPLANTATION», 2015, 50, pp. 1037 - 1056 [Scientific article]
Lanza F., Issue Highlight 2015, «CYTOMETRY. PART B, CLINICAL CYTOMETRY», 2015, 88, pp. 283 - 285 [Scientific article]
F. Castagnetti; G. Gugliotta; M. Breccia; F. Stagno; A. Iurlo; F. Albano; E. Abruzzese; B. Martino; L. Levato; T. Intermesoli; P. Pregno; G. Rossi; F. Gherlinzoni; P. Leoni; F. Cavazzini; C. Venturi; S. Soverini; N. Testoni; G. Alimena; M. Cavo; G. Martinelli; F. Pane; G. Saglio; G. Rosti; M. Baccarani; [GIMEMA CML Working Party]; F. Palandri; F. Lanza;, Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib, «LEUKEMIA», 2015, 29, pp. 1823 - 1831 [Scientific article]
Buchi, F; Ravelli, A; Olivieri, A; Pierelli, L; Lemoli, R; Accorsi, P; Lanza, F; Bosi, A, Move on air: Webinar for education in stem cells mobilization Report I, «DRUGS AND CELL THERAPIES IN HEMATOLOGY», 2015, 3, pp. 100 - 105 [Scientific article]
Lazzari, MC; Ongari, M; Di Martino, G; Ravelli, A; Vigano, CV; Brambilla, P; Spedini, P; Lanza, F, Novel Applications for the Flow Cytometry, «DRUGS AND CELL THERAPIES IN HEMATOLOGY», 2015, 3, pp. 65 - 70 [Scientific article]